ABSTRACT: Dementia of the Alzheimer type (DAT) has proven to be difficult to diagnose using computerized X-ray tomography (CT). To improve the identification of DAT with CT, several different quantitative approaches have been tried. Brain parenchymal density measurements and a variety of linear indices of ventricular size have failed to reliably separate DAT patients from age matched controls. Measures of ventricular volume improve discrimination, but overlap with controls persists. The inadequacy of a single CT study to diagnose DAT is clearly related to the overlap of brain atrophy in DAT and healthy aging, a finding which has also been noted in post-mortem studies. Estimating the rate of ventricular enlargement from quantitative measurements of ventricular size on successive CT scans may allow the physician to take advantage of the progressive nature of DAT, improving separation of DAT patients from healthy controls. RESUME: Tomographic quantitative a rayons X assistee par ordinateur dans la demence de type Alzheimer. II s'est avere difficile de diagnostiquer la demence de type Alzheimer (DTA) au moyen de la tomographic par rayons X assistee par ordinateur (TAO). Plusieurs approches quantitatives differentes ont ete essayees dans le but d'ameliorer 1'identification de la DTA au moyen de la TAO. II a ete impossible de separer de fagon fiable les patients atteints de DTA de temoins apparies pour l'age, au moyen de mesures de la densite du parenchyme du cerveau et d'index lineaires varies de la taille des ventricules. Les mesures de volumes ventriculaires ameliorent la discrimination, mais il persiste un chevauchement avec les mesures des temoins. Le fait qu'un seul examen par TAO soit inadequat pour poser le diagnostic de DTA est, de toute evidence, relie au chevauchement des mesures de l'atrophie du cerveau chez les patients atteints de DTA et les vieillards sains, une observation qui a egalement ete notee dans les etudes effectuees en post-mortem. L'estimation de la vitesse d'agrandissement des ventricules a partir de mesures quantitatives de la taille des ventricules sur des TAO successives peut permettre au medecin de profiter de la nature progressive de la DTA pour ameliorer la separation des patients atteints de DTA des temoins normaux.
Computerized X-ray transverse axial tomography (CT) of the brain was introduced in 1973' and has subsequently found wide application in neurology. Progressive dementing illnesses have proven difficult to diagnose accurately in life, and soon after its introduction the CT technique was used to study dementia. 2 CT correlates strongly with pneumoencephalography, 3 the invasive technique previously used to judge ventricular enlargement. In addition, CT is useful in demonstrating subdural hematomas, tumors, normal pressure hydrocephalus and other potentially treatable causes of the dementia syndrome. 2 CT also allows detection of clinically unsuspected infarctions 2 helpful in diagnosing multiinfarct dementia, 4 the second most common form of dementing illness in the elderly. 5 It was soon recognized, however, that the most common form of dementing illness, dementia of the Alzheimer type (DAT), 5 shows changes on CT that overlap 2 considerably with those in age matched control subjects. Takedaand Matsuzawa   6 and Schwartz 7 showed increased ventricular size with advanced age in healthy subjects, making the diagnosis of DAT on the basis of CT findings difficult in the old patient. Necropsy studies have shown that the enlargement of ventricles and loss of cortical gray matter and central white matter in DAT are variable and overlap 8 with age matched controls. However, post-mortem studies of brain atrophy are difficult to quantitate and suffer from the variable effects of fixation on brain volume. 8 Studies of the relationships of cortical atrophy in DAT to the behavioral features of the disease, and comparisons to age related atrophy are best performed with CT.
Several different approaches toward improved discrimination of DAT using CT have been attempted. The brain parenchymal density measurements in Hounsfield units (HU) reflect true tissue X-ray attenuation. The density of gray matter and white matter, as well as the difference between the two tissue types, have been studied qualitatively 9 and quantitatively 9 "" in DAT. Loss of gray-white discrimination 9 and decreased mean density" were shown, but in both studies the level measured was in part determined by the ventricular size, known to be often increased in DAT. The level of a particular CT slice in relation to the base of the skull influences the degree that the density values are artifactually elevated by the proximity to bone, the "beam hardening" effect. 12 Controlling for position in the skull, Gado 10 found no evidence of a loss of CT density in DAT.
In an attempt to improve discrimination between DAT and healthy aging, a variety 213 "' 8 of linear indices of ventricular size have been measured. In general, these techniques have not permitted adequate separation of patient groups, although in young patients with DAT, Albert 18 was able to correctly assign 79% of patients and age matched controls. Measures of' 'cortical atrophy" have been attempted, including width of the largest sulci 219 and the outline of the perimeter of the brain traced, then standardized to cranial size. 20, 21 Again, these measures have not proven valuable in differentiating DAT from healthy aging and other degenerative dementias.
The irregular shape of the cerebral ventricles contributes to the difficulty in reliably measuring ventricular size. By summing the ventricular area on serial CT slices, and multiplying the sum by the interslice distance, ventricular volumes can be calculated. 22 Whereas thin slices would be expected to maximize the accuracy of such an integration, the loss of planar resolution with a given radiation dose and thinner slices limit the use of this volumetric technique to slices that are 8-10 mm thick. 6 -722, 23 Computer software for semi-automated volumetric analysis of brain atrophy have been described. 24, 25 Although volumetric measurements of ventricular size have improved group differences 22 between DAT and controls, considerable overlap persists, 22 ' 26 particularly in patients with mild DAT. 26 The inadequacy of a single CT scan, 2728 no matter what measure of brain atrophy is used, to diagnose DAT is clearly related to the overlap of brain atrophy in DAT and healthy aging. A longitudinal approach, however, can take advantage of the progressive nature of DAT. Gado 29 showed enlargement of linear indices of ventricular size in 21 patients with mild DAT over approximately one year of follow-up. In a similar study of healthy aging, 22 volumetric measures were found to be more sensitive than linear indices in showing ventricular enlargement. Brinkman 30 et al showed that linear indices of ventricular size showed more rapid enlargement in 4/5 DAT patients than the rate of control subjects calculated from a cross-sectional study. Our laboratory 31 recently has found that volumetric measures of lateral ventricular enlargement completely separated a group of 12 patients with DAT from 12 healthy age-matched controls. Third ventricular enlargement did not successfully separate these groups, possibly because of the difficulty measuring the relatively small volume of the third ventricle with CT.
3 ' The utility of serial CT scanning in diagnosing DAT needs to be confirmed with larger studies, incorporating patients with mild and/or early disease where diagnosis is most difficult. Specificity must be explored by studying other dementing illnesses that can be confused with DAT. To insure maximal accuracy, careful attention must be paid to positioning the patient in the scanner in a standardized, easily reproducible manner. Investigators must be trained to maximize intrarater and interrater reliability of measurements.
The apparent size of an anatomic structure in a CT image can vary depending on the display settings determined by the viewing physician. 32, 33 Methods of quantitative analysis of CT images often require the analyst to outline regions of interest;
29 the viewing window must be standardized 7 to insure consistency across serial scans. The apparent size of objects is also related to slice thickness (collimator width). 33 The technique used for CT scanning should therefore be the same for each scan in a serial study. Ideally, the same CT scanner should be used for each scan, and careful daily calibration should be used with phantoms of several X-ray densities.
The advent of magnetic resonance imaging (MRI) may provide a useful method of serial scanning without radiation exposure. MRI measures of cerebral atrophy correlate strongly with CT measures. 34, 35 The thinner slice thickness theoretically obtainable with MRI will minimize partial voluming artifacts. The accuracy of area measurements using current commercially available CT and MRI has been compared by Zhu 36 et al. However, present MRI scanning is often less accurate than CT in measuring the area of phantoms. 36 Additional problems with the use of MRI for quantitative studies include the difficulty of calibration, the length of time necessary for the patient to hold still for the scan, and the difficulty of reproducibly positioning the patient in the scanner.
